Biocon
Pharma, healthcare growing, but they face challenges beyond Covid-19
Biocon gains 2% after arm gets Rs 555 crore capital injection from ADQ
Stocks to watch: TCS, Biocon, Bharat Rasayan, Vodafone Idea, Tata Power
Biocon: Street to keep an eye on CY21 launches, market share gains
Nifty outlook and stock recommendations by Sameet Chavan of Angel Broking

USFDA informs Biocon, Mylan of deferred action on biosimilar license plea
Hopefully DCGI to give nod for Oxford's vaccine immediately: Biocon chief
Biocon Biologics gets capital injection of $150 mn from Goldman Sachs
Strong prospects of Biologics business keep Street positive on Biocon
Sebi levies fine on Biocon employee for violating insider trading norms

Biocon posts 22% fall in Q2 net profit on high R&D expenses, staff costs
India has potential to increase Covid testing 10-fold: Kiran Mazumdar-Shaw
Forbes India Rich List 2020: Ambani dominance continues; see full list
Sales of Biocon's itolizumab surge as phase-4 clinical trials begin
Biocon set for bigger insulin play, aims to reach one in five diabetics
Pick-up in biosimilar launches driving Biocon's prospects; stock rises 7.8%
Biocon shares up 6% after Co launches insulin glargine in US market
Biocon-Mylan launch insulin Glargine at lowest price in US market
Weekly trading ideas by Religare Broking: Buy Grasim Industries, Biocon
Biocon chairperson Kiran Mazumdar-Shaw tests positive for Covid-19